Skip to content

Why $10 billion for AIDS?

Merck unveils integrase inhibitor

Antiretroviral access: experience from Haiti

Nutrition, the neglected side of AIDS care in developing countries

Fusion inhibitor provides superior salvage

Private sector ARV schemes in Africa report progress

Further data on pegylated interferon in HCV/HIV coinfection

NRTI-sparing regimen achieves better viral suppression

Switch to atazanavir associated with cholesterol and triglyceride reductions